ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
22/01/2025
Voltar para busca
Dado oficial do USPTO
NEGEDIA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
14
Atualização mais recente
23/01/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
08/02/2022
Data de registro
14/03/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/03/2023
Última transação
23/01/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
POZZUOLI (NA), IT
Examinador
BHANOT, KAPIL
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
NEGEDIA S.R.L.
Next Generation Diagnostic Srl
Representantes
MICHAEL J. HYNAK HYNAK & ASSOCIATES, PC
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific research for medical purposes in the field of genetic sciencegenetic engineeringrare diseasesoncology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of genetic science; Medical research in the field of oncology; Computer programming in the medical field; Development of new technology for others in the field of genomicsbiotechnologyDNA screening; Structural and functional analysis of genomes; Scientific and technological servicesresearch and design in the field of medical diagnostic equipment; Providing laboratory research services in the field of gene expressioncancer biology; Chemicalbiochemicalbiological and bacteriological research and analysis; Research and development in the pharmaceutical and biotechnology fields; Technical research in the field of pharmaceutical studies; Pharmaceutical research and development; Consulting services in the field of pharmacogenetics; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Providing medical testing services and information in the field of cancer research and disease classification; Scientific and technological servicesscientific researchanalysistesting in the field of geneticsoncologyrare diseasesmolecular biology; Research and development of vaccines and medicines; Researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines; DNA screening for scientific research purposes; Providing an on-line searchable database in the field of geneticsrare diseases and oncology for scientific research purposes; Research and development services in the field of antibodies; Pharmaceutical product evaluation; Testing of pharmaceuticals; Laboratory research in the field of bacteriologychemistryphysicscytologygeneticssequencing; Bacteriological research and analysis; Scientific research for medical purposes in the field of geneticsrare diseasescancersequencingbiotechnology;
Classe 44
Genetic testing for medical purposes; Performing diagnosis of diseases; Testing for medical diagnostic or treatment purposes in the field of infectious diseases; Medical screening services in the field of geneticsoncology and rare diseases; Providing medical information to medical professionals and research establishments in the form of reports in the field of rare diseasepharmaceutical-gene interactionsgeneticsoncology; DNA screening for medical purposes; Medical screening; Antibody testing for medical diagnostic or treatment purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
14 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
14/03/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
14/03/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/12/2022
PUBO
PUBLISHED FOR OPPOSITION
27/12/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/11/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
22/11/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/11/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
22/11/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/11/2022
DOCK
ASSIGNED TO EXAMINER
21/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/02/2022
NWAP
NEW APPLICATION ENTERED
11/02/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEGEDIA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.